Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects

被引:0
|
作者
De Vries, R
Wolffenbuttel, BHR
Sluiter, WJ
Van Tol, A
Dullaart, RPF
机构
[1] Univ Groningen, Med Ctr, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands
关键词
adiponectin; HDL cholesterol; hepatic lipase; lipoprotein lipase; triglycerides; type 2 diabetes mellitus;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The aim of this study was to determine the relationships of plasma adiponectin with post-heparin plasma lipoprotein lipase (LPL) and hepatic lipase (HL) activities, and to evaluate whether plasma adiponectin contributes to diabetes-associated dyslipidaemia. Plasma adiponectin, post-heparin plasma lipase activities, lipoproteins and insulin sensitivity (hyperinsulinaemic euglycaemic clamp) were measured in 24 male type 2 diabetic patients and 24 age-matched healthy men. Plasma triglycerides (P < 0.01) and apolipoprotein B levels (P < 0.01) were higher, and HDL cholesterol was lower (P < 0.05) in type 2 diabetic patients. Plasma adiponectin, as well as LPL and HL activities were not significantly different between diabetic and healthy subjects. Multiple regression analysis showed that LPL activity was positively related with plasma adiponectin (P < 0.05). In contrast, HL activity was positively related with body mass index (P < 0.02) and waist/hip ratio (P < 0.05, multiple r = 0.74), but not with plasma adiponectin. Plasma adiponectin was positively associated with insulin sensitivity (P = 0.001), age (P < 0.02) and LPL activity (P < 0.05, multiple r = 0.64), but not with the presence of diabetes and HL activity. Plasma triglycerides were negatively related with LPL activity (P = 0.002) and positively with the diabetic state (P = 0.001, multiple r = 0.58). HDL cholesterol was positively related with plasma adiponectin (P = 0.003) and negatively with HL activity (P < 0.02) as well as with the presence of diabetes (P = 0.05, multiple r = 0.59). We conclude that post-heparin plasma LPL activity, but not HL activity, is related with plasma adiponectin. Plasma adiponectin appears to be a determinant of plasma triglycerides via an effect on LPL activity. It seems unlikely that plasma adiponectin predicts the effects of the diabetic state as such on high plasma triglycerides and low HDL cholesterol.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 41 条
  • [21] Tacrolimus-Induced Elevation in Plasma Triglyceride Concentrations After Administration to Renal Transplant Patients Is Partially Due to a Decrease in Lipoprotein Lipase Activity and Plasma Concentrations
    Tory, Rita
    Sachs-Barrable, Kristina
    Goshko, Caylee-Britt
    Hill, John S.
    Wasan, Kishor M.
    TRANSPLANTATION, 2009, 88 (01) : 62 - 68
  • [22] Association of 276G>T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients
    Ina Maria Kacso
    Adrian Pavel Trifa
    Radu Anghel Popp
    Gabriel Kacso
    International Urology and Nephrology, 2012, 44 : 1771 - 1777
  • [23] Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
    Hotta, K
    Funahashi, T
    Arita, Y
    Takahashi, M
    Matsuda, M
    Okamoto, Y
    Iwahashi, H
    Kuriyama, H
    Ouchi, N
    Maeda, K
    Nishida, M
    Kihara, S
    Sakai, N
    Nakajima, T
    Hasegawa, K
    Muraguchi, M
    Ohmoto, Y
    Nakamura, T
    Yamashita, S
    Hanafusa, T
    Matsuzawa, Y
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) : 1595 - 1599
  • [24] The -250G&gt;A polymorphism in the hepatic lipase gene promoter influences plasma lipid profile and lipoprotein ratio in patients with ischemic stroke
    Momoh, Johnson Oshiobugie
    Osuntoki, Akinniyi Adediran
    Ebuehi, Osaretin Albert Taiwo
    Ajibaye, Olusola
    JOURNAL OF ACUTE DISEASE, 2021, 10 (01) : 28 - 35
  • [25] Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians
    Nayak, B. Shivananda
    Ramsingh, Deepak
    Gooding, Shanaree
    Legall, George
    Bissram, Sanjiu
    Mohammed, Atif
    Raychaudhuri, Anupama
    Sahadeo, Brad
    Pandohie, Varoon
    Figaro, Kemron
    PRIMARY CARE DIABETES, 2010, 4 (03) : 187 - 192
  • [26] Association of 276G&gt;T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients
    Kacso, Ina Maria
    Trifa, Adrian Pavel
    Popp, Radu Anghel
    Kacso, Gabriel
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (06) : 1771 - 1777
  • [27] Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents
    Hanyu, Osamu
    Miida, Takashi
    Kosuge, Keiichiro
    Ito, Takako
    Soda, Satoshi
    Hirayama, Satoshi
    Wardaningsih, Elfi
    Fueki, Yuriko
    Obayashi, Konen
    Aizawa, Yoshifusa
    CLINICA CHIMICA ACTA, 2007, 384 (1-2) : 118 - 123
  • [28] Alzheimer's like brain changes correlate with low adiponectin plasma levels in type 2 diabetic patients
    Garcia-Casares, Natalia
    Garcia-Ames, Juan A.
    Rioja, Jose
    Jose Ariza, Maria
    Gutierrez, Antonio
    Alfaro, Francisco
    Nabrozidis, Alejandro
    Gonzalez-Alegre, Pedro
    Gonzalez-Santos, Pedro
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (02) : 281 - 286
  • [29] The effect of apolipoprotein E polymorphism on plasma cholesteryl ester transfer protein activity in type 2 diabetic patients
    Chaaba, R.
    Attia, N.
    Hammami, S.
    Smaoui, M.
    Ben Hamda, K.
    Mahjoub, S.
    Hammami, M.
    MOLECULAR BIOLOGY, 2008, 42 (06) : 829 - 833
  • [30] The effect of apolipoprotein E polymorphism on plasma cholesteryl ester transfer protein activity in type 2 diabetic patients
    R. Chaaba
    N. Attia
    S. Hammami
    M. Smaoui
    K. Ben Hamda
    S. Mahjoub
    M. Hammami
    Molecular Biology, 2008, 42 : 829 - 833